Steroid-Based Therapy and Risk of Infectious Complications
Lionel Rostaing and Paolo Malvezzi discuss the clinical implications of Laurence Fardet and colleagues' accompanying research study on infectious complications in patients receiving steroid treatment.
Vyšlo v časopise:
Steroid-Based Therapy and Risk of Infectious Complications. PLoS Med 13(5): e32767. doi:10.1371/journal.pmed.1002025
Kategorie:
Perspective
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1002025
Souhrn
Lionel Rostaing and Paolo Malvezzi discuss the clinical implications of Laurence Fardet and colleagues' accompanying research study on infectious complications in patients receiving steroid treatment.
Zdroje
1. Overman RA, Yeh JY, Deal CL. Prevalence of oral glucocorticoid usage in the United States: a general population perspective. Arthritis Care Res. 2013;65:294–298.
2. Fardet L, Petersen I, Nazareth I. Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years. Rheumatology. 2011;50:1982–1990. doi: 10.1093/rheumatology/ker017 21393338
3. Kass EH, Finland M. Corticosteroids and infections. Adv Intern Med. 1958;9:45–80. 13636912
4. Hoes JN, Jacobs JW, Verstappen SM, Bijlsma JW, Van der Heijden GJ. Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis. Ann Rheum Dis. 2009;68:1833–1838. doi: 10.1136/ard.2008.100008 19066177
5. Stuck A, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticoids. Clin Infect Dis. 1989;11:954–963.
6. Dixon WG, Kezouh A, Bernatsky S, Suissa S. The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study. Ann Rheum Dis. 2011;70:956–960. doi: 10.1136/ard.2010.144741 21285116
7. Fardet L, Petersen I, Nazareth I. Common infections in patients prescribed systemic glucocorticoids in primary care: a population-based cohort study. PLoS Med. 2016;13(5):e1002024.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2016 Číslo 5
- Mobilní aplikace jako nová možnost v prevenci napadení klíštětem
- Hydroresponzivní krytí v epitelizační fázi hojení rány
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Metabolit živočišné stravy produkovaný střevní mikroflórou zvyšuje riziko závažných kardiovaskulárních příhod
Najčítanejšie v tomto čísle
- Estimating the Risk of Chronic Pain: Development and Validation of a Prognostic Model (PICKUP) for Patients with Acute Low Back Pain
- Prioritizing Surgical Care on National Health Agendas: A Qualitative Case Study of Papua New Guinea, Uganda, and Sierra Leone
- A Revolution in Treatment for Hepatitis C Infection: Mitigating the Budgetary Impact
- Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola